Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: Cancer. 2013 Jun 6;119(15):2675–2682. doi: 10.1002/cncr.28130

Table 1.

Patient Characteristics by sHER2 group at baseline.

Characteristic sHER2 <15
N=2029 (88)
No. Patient (%)
Chi-square
p-value
sHER2 ≥15
N=289 (12)
No. Patient (%)
Cohort Patients
N=2318 (74)
No. Patient (%)
Chi-square
p-value
Non-Cohort Patients
N=815 (26)
No. Patient (%)

Age (median) 49 (19–82) 53 (23–80) 49 (19–82) 50 (22–79)

Age Group:
<40 373 (18) <0.0001* 26 (9) 399 (17) 0.15* 145 (18)
40–49 691 (34) 85 (29) 776 (33) 261 (32)
50–59 669 (33) 113 (39) 782 (34) 238 (29)
≥ 60 296 (15) 65 (22) 361 (16) 171 (21)

Race:
White 1723 (85) 0.08 234 (81) 1957 (84) 0.05 664 (81)
Other 306 (15) 55 (19) 361 (16) 151 (19)

Menopausal Status:
Pre-menopausal or < 50 1147 (57) <0.0001 107 (37) 1254 (54) 0.59 432 (53)
Post-menopausal or ≥ 50 882 (43) 182 (63) 1064 (46) 383 (47)

ER/PR Status:
ER or PR Positive 1112 (55) 0.01 135 (47) 1247 (54) 0.78 443 (54)
Other 917 (45) 154 (53) 1071 (46) 372 (46)

Surgery:
Breast Conserving 796 (39) 0.77 116 (40) 912 (39) 0.18 299 (37)
Mastectomy 1233 (61) 173 (60) 1406 (61) 516 (63)

Nodal Status:
Positive 1751 (86) 0.09 260 (90) 2011 (87) 0.93 706 (87)
Negative 278 (14) 29 (10) 307 (13) 109 (13)

Predominant Histology:
Ductal 1922 (95) 0.98± 274 (95) 2196 (95) 0.51± 767 (94)
Lobular 59 (3) 8 (3) 67 (3) 30 (4)
Other 46 (2) 7 (2) 53 (2) 17 (2)
Missing 2 (0.1) 0 (0) 2 (0.1) 1 (0.2)

Histologic Tumor Grade (Elston/SBR):
Well/Intermediate 589 (29) 0.12 71 (25) 660 (28) 0.84 235 (29)
Poor 1440 (71) 218 (75) 1658 (72) 580 (71)

Pathologic Tumor Size:
< 2 cm 705 (35) 0.07 85 (29) 790 (34) 0.02 242 (30)
≥ 2 cm 1324 (65) 204 (71) 1528 (66) 573 (70)

Hormonal Treatment:
Yes 1088 (54) 0.0002 122 (42) 1210 (52) 0.77± 418 (51)
No 930 (46) 166 (57) 1096 (47) 388 (48)
Missing 11 (0.5) 1 (0.3) 12 (0.5) 9 (1)
*

Mantel-Haenszel trend test,

±

Missing not included in comparison